Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
83.4M
-
Shares change
-
+9.33M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$191M
-
Put/Call ratio
-
2.1
-
Number of buys
-
138
-
Number of sells
-
-83
-
Price
-
$19.20
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2017
277 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2017.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.4M shares
of 93.1M outstanding shares and own 89.59% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (9.92M shares), BlackRock Inc. (9.54M shares), VANGUARD GROUP INC (6.25M shares), Camber Capital Management LLC (4.33M shares), D. E. Shaw & Co., Inc. (4.2M shares), STATE STREET CORP (3.18M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (3.08M shares), Consonance Capital Management LP (2.98M shares), DIMENSIONAL FUND ADVISORS LP (2.64M shares), and MILLENNIUM MANAGEMENT LLC (2.02M shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.